Ulcerative form of pyoderma gangrenosum (a case study description)

Cover Page

Cite item

Full Text

Abstract

The authors describe a case of pyoderma gangrenosum when the patient’s external therapy included Tecasorb disposable sterile tissue-based absorption wipes featuring activated carbon manufactured based on nanotechnologies. The authors describe and confirm that the following present-day study method can be used for diagnostics of the disease: mass spectrometry of microbial agents in biological environments.

About the authors

A. V. Patrushev

Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russian Federation Akademika

Author for correspondence.
Email: alexpat2@yandex.ru
Russian Federation

A. V. Samtsov

Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russian Federation Akademika

Russian Federation

V. V. Barbinov

Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russian Federation Akademika

Russian Federation

A. V. Sukharev

Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russian Federation Akademika

Russian Federation

I. E. Belousova

Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russian Federation Akademika

Russian Federation

A. . S Chizhov

Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russian Federation Akademika

Russian Federation

References

  1. Европейское руководство по лечению дерматологических болезней. Под. ред. А.Д. Кацамбаса, Т.М. Лотти. М: МЕДпресс-информ; 2008
  2. Saracino A., Kelly R., Liew D. et al. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up. Austr J Dermatol 2011; 52 (3): 218-21.
  3. Thompson D.N., Main R.A., Beck J.S. Studies on a patient with leukocytoclastic vasculitis, Pyoderma gangrenosum and paraproteinemia. British Journal of Dermatology 1973; 88: 117-25.
  4. Осипов Г.А. Количественный in situ микробиологический анализ по липидным маркерам в биологических жидкостях с использованием метода газовой хроматографии - масс-спектрометрии. Здравоохранение - медицинские технологии 2007; (5): 20-3
  5. Осипов Г.А., Родионов Г.Г. Применение метода масс-спектрометрии микробных маркеров в клинической практике. Лаборатория 2013; (2): 68-73

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Patrushev A.V., Samtsov A.V., Barbinov V.V., Sukharev A.V., Belousova I.E., S Chizhov A...

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).